Prostate cancer and its associated TME can also disrupt antitumor T-cell function via immunosuppression from inhibitory checkpoint molecules like PD-L1, altered levels of molecules involved in metabolic and inflammatory pathways, and impaired tumor cell apoptosis. Here, CD274 is linked to Familial prostate cancer.